The value of the UroVysion® FISH assay in the risk-stratification of patients with "atypical urothelial cells" in urinary cytology specimens (Q48292323)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The value of the UroVysion® FISH assay in the risk-stratification of patients with "atypical urothelial cells" in urinary cytology specimens	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/28397365

The value of the UroVysion® FISH assay in the risk-stratification of patients with "atypical urothelial cells" in urinary cytology specimens (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/28397365

Stefan E Pambuccian

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28397365%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

author name string

Renu K Virk

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28397365%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Schuharazad Abro

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28397365%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Julianne Muus Martinez de Ubago

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28397365%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Marcus L Quek

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28397365%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Eva M Wojcik

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28397365%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Swati Mehrotra

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28397365%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Grazina U Chatt

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28397365%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Güliz A Barkan

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28397365%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

publication date

11 April 2017

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/28397365

Diagnostic Cytopathology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28397365%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

45

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28397365%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28397365%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

481-500

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28397365%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Cancer statistics, 2015

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

Can we still afford bladder cancer?

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

The Paris System for Reporting Urinary Cytology: The Quest to Develop a Standardized Terminology

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

An international telecytologic quiz on urinary cytology reveals educational deficits and absence of a commonly used classification system.

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

Evaluation of atypical urine cytology progression to malignancy.

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

The diagnostic accuracy of urine-based tests for bladder cancer varies greatly by patient

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

Prospective evaluation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

Prospective validation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

Bladder cancer detection using FISH (UroVysion assay).

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

Urinary Biomarkers for Diagnosis of Bladder Cancer: A Systematic Review and Meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

It May Be Time to Abandon Urine Tests for Bladder Cancer.

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

UroVysion® multiprobe FISH in the triage of equivocal urinary cytology cases

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

Role of fluorescence in situ hybridization in bladder cancer surveillance of patients with negative cytology

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

Prognostic relevance of positive urine markers in patients with negative cystoscopy during surveillance of bladder cancer.

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

Evaluation of urovysion and cytology for bladder cancer detection: a study of 1835 paired urine samples with clinical and histologic correlation

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

Fluorescence in situ hybridization for detecting urothelial carcinoma: a clinicopathologic study

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

UroVysion FISH test for detecting urothelial cancers: meta-analysis of diagnostic accuracy and comparison with urinary cytology testing

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

Role of Tetrasomy for the Diagnosis of Urothelial Carcinoma Using UroVysion Fluorescent In Situ Hybridization.

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

The positive predictive value of "suspicious for high-grade urothelial carcinoma" in urinary tract cytology specimens: A single-institution study of 665 cases.

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

Diagnosis and classification of flat, papillary, and invasive urothelial carcinoma: the WHO/ISUP consensus

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

Molecular markers for bladder cancer screening, early diagnosis, and surveillance: the WHO/ICUD consensus

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

Does polyomavirus infection interfere with bladder cancer fluorescence in situ hybridization?

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

Exclusion of the uniform tetraploid cells significantly improves specificity of the urine fish assay

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

Comparison of different concepts for interpretation of chromosomal aberrations in urothelial cells detected by fluorescence in situ hybridization.

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

A retrospective review of UroVysion fish interpretations over 8.6 years: a major shift in the patient test population.

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

Prospective trial to identify optimal bladder cancer surveillance protocol: reducing costs while maximizing sensitivity

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

Hematuria as a Marker of Occult Urinary Tract Cancer: Advice for High-Value Care From the American College of Physicians

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

Comparison of Guidelines on Non-Muscle Invasive Bladder Cancer (EAU, CUA, AUA, NCCN, NICE)

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

Follow-up in non-muscle-invasive bladder cancer-International Bladder Cancer Network recommendations

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

A review of the Paris system for reporting urinary cytology

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

Impact of Implementing the Paris System for Reporting Urine Cytology in the Performance of Urine Cytology: A Correlative Study of 124 Cases.

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

Two-tiered subdivision of atypia on urine cytology can improve patient follow-up and optimize the utility of UroVysion.

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

Nongynecologic cytology practice patterns: a survey of participants in the College of American Pathologists interlaboratory comparison program in nongynecologic cytopathology.

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

"FISHing" to detect urinary and other cancers: validation of an imaging system to aid in interpretation

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

A practical guide to epidemiological practice and standards in the identification and validation of diagnostic markers using a bladder cancer example.

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

Verification bias in diagnostic accuracy studies for fine- and core needle biopsy of salivary gland lesions in otolaryngology journals: a systematic review and analysis

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

21 January 2018

The role of urinary cytology for detection of bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness of fluorescence in situ hybridization in patients with atypical cytology for the detection of urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

7 January 2021

based on heuristic

inferred from DOI database lookup

Should we abandon the FISH test?

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

7 January 2021

based on heuristic

inferred from DOI database lookup

What should not be reported as atypia in urine cytology

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

7 January 2021

based on heuristic

inferred from DOI database lookup

Modified UroVysion scoring criteria increase the urothelial carcinoma detection rate in cases of equivocal urinary cytology

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

7 January 2021

based on heuristic

inferred from DOI database lookup

Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findings

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter evaluation of the role of UroVysion FISH assay in surveillance of patients with bladder cancer: does FISH positivity anticipate recurrence?

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of chromosomal aberrations in patients with benign conditions and reactive changes in urinary cytology

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

7 January 2021

based on heuristic

inferred from DOI database lookup

Multi-target fluorescence in situ hybridization in bladder washings for prediction of recurrent bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

7 January 2021

based on heuristic

inferred from DOI database lookup

EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

7 January 2021

based on heuristic

inferred from DOI database lookup

What is atypia? Use, misuse and overuse of the term atypia in diagnostic cytopathology

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

7 January 2021

based on heuristic

inferred from DOI database lookup

The Paris System for Reporting Urinary Cytology: the quest to develop a standardized terminology

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

7 January 2021

based on heuristic

inferred from DOI database lookup

Application of The Paris System to atypical urine cytology samples: correlation with histology and UroVysion® FISH

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessing the value of reflex fluorescence in situ hybridization testing in the diagnosis of bladder cancer when routine urine cytological examination is equivocal

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

7 January 2021

based on heuristic

inferred from DOI database lookup

The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiprobe Fluorescence in situ Hybridization (UroVysion) for the Detection of Urothelial Carcinoma – FISHing for the Right Catch

1 reference

https://api.crossref.org/works/10.1002%2FDC.23686

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48292323&oldid=2194343356"